Literature DB >> 812426

Lupus-scleroderma syndrome induced by ethosuximide.

P C Teoh, H L Chan.   

Abstract

Features of both systemic lupus erythematosus and scleroderma developed in a young Chinese girl while on multiple anticonvulsant therapy. These were reversed after withdrawal of the drugs. Readministration of ethosuximide for control of epilepsy caused a relapse with predominant sclerodermatous features. These clinical signs again resolved after ethosuximide withdrawal.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 812426      PMCID： PMC1545540          DOI： 10.1136/adc.50.8.658

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Modern concepts of systemic lupus erythematosus; a review of 126 cases.

Authors:  J R HASERICK
Journal:  J Chronic Dis       Date:  1955-03

Review 2.  Classification and pathogenesis of scleroderma.

Authors:  R K Winkelmann
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

3.  Systemic lupus erythematosus. Occurrence in association with ethosuximide therapy.

Authors:  S Livingston; H Rodriguez; C A Greene; L L Pauli
Journal:  JAMA       Date:  1968-05-20       Impact factor: 56.272

Review 4.  Drug-induced lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Mayo Clin Proc       Date:  1969-09       Impact factor: 7.616
  4 in total
  2 in total

Review 1.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  New-onset systemic sclerosis and scleroderma renal crisis under docetaxel.

Authors:  Véronique Debien; Arthur Petitdemange; Dorothée Bazin; Carole Ederle; Benoit Nespola; Hamid Merdji; Jérome Olagne; Thierry Martin; Aurélien Guffroy; Carole Pflumio
Journal:  J Scleroderma Relat Disord       Date:  2021-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.